 |
    | | ||
 |
 | |||
 |
|
 | ||
 | ||||
|
|
  Cytomedix develops biologically active regenerative therapies for wound care, angiogenesis, and inflammation. Our goal is to harness the complex balance of essential life processes, functions and activities that mirror the potent therapeutic effects of the human body, to treat complex medical conditions. Read more about our company.  Webcast Presentation - Cytomedix at The 8th Annual BIO Investor Forum - Thursday, October 29 2:30 PM PT Cytomedix Announces Registered Direct Offering of Common Stock and Warrants Cytomedix Second Quarter Financial Results Feature Product Sales Up 72% Over First Quarter Read all press releases.  The AutoloGel System harnesses the patient's natural healing processes with the delivery of a platelet releasate gel containing growth factors, cytokines and chemokines required for cell growth and formation of new tissue. Restoring the balance in the wound environment can transform a non healing wound to a wound that heals naturally. Continue > 
|
| ||
 |
  | |||
| © 2009 Cytomedix. All Rights Reserved. | Site Map | Terms & Conditions |